GPT and Hyperbilirubinemia: Following the exclusion of all dogs with evidence to support possible hepatic involvement (confirmed liver disease, ALT or ALP elevation, bile acid elevation, and/or hyperbilirubinaemia), 26/116 dogs had detectable BA (median 14 μg/dL, IQR 6 μg/dL, range 7–38 μg/dL).